4
Changes in Ownership
PharmaCyte Biotech, Inc. Filed Acc 0001683168-26-000148
CEO and President bought 100,000 shares at an average $0.80 ($80,476)
From the SEC's structured data for this filing
Trades in this filing
Silverman Joshua · CEO and President
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-05 | Purchase : show line 1 in the form | +30,000 | $0.78 | $23,493 | 346,250 | D |
| 2026-01-06 | Purchase : show line 2 in the form | +30,000 | $0.79 | $23,667 | 376,250 | D |
| 2026-01-07 | Purchase : show line 3 in the form | +40,000 | $0.83 | $33,316 | 416,250 | D |
| Open-market purchases · 100,000 sh · avg $0.80 · $80,476 | ||||||
Loading xslF345X05/ownership.xml…